Aetna (AET) Receives “Neutral” Rating from Credit Suisse Group
Aetna (NYSE:AET)‘s stock had its “neutral” rating restated by investment analysts at Credit Suisse Group in a report released on Wednesday, The Fly reports. They presently have a $195.00 price target on the stock, up from their previous price target of $174.00. Credit Suisse Group’s price objective would suggest a potential upside of 9.13% from the stock’s previous close.
Other equities research analysts also recently issued research reports about the stock. BMO Capital Markets raised their price objective on shares of Aetna from $175.00 to $200.00 and gave the stock a “market perform” rating in a research note on Friday, October 27th. Argus restated a “buy” rating and issued a $185.00 price objective (up previously from $165.00) on shares of Aetna in a research note on Tuesday, September 12th. Cantor Fitzgerald downgraded shares of Aetna from an “overweight” rating to a “neutral” rating in a research note on Thursday, October 26th. Zacks Investment Research upgraded shares of Aetna from a “hold” rating to a “strong-buy” rating and set a $184.00 price objective on the stock in a research note on Wednesday, October 25th. Finally, Raymond James Financial upgraded shares of Aetna from a “market perform” rating to an “outperform” rating and set a $200.00 price objective on the stock in a research note on Friday, November 3rd. Twelve investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $175.19.
Aetna (AET) opened at $178.69 on Wednesday. Aetna has a 52-week low of $116.04 and a 52-week high of $192.37. The company has a market cap of $58,274.07, a P/E ratio of 17.50, a PEG ratio of 1.63 and a beta of 0.61. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.53 and a quick ratio of 0.53.
In other Aetna news, EVP Margaret M. Mccarthy sold 10,288 shares of Aetna stock in a transaction on Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the completion of the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at $5,465,734.55. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, President Karen S. Lynch sold 15,271 shares of Aetna stock in a transaction on Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the transaction, the president now directly owns 64,261 shares of the company’s stock, valued at $10,404,498.51. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.
Several institutional investors have recently added to or reduced their stakes in the stock. AXA grew its position in shares of Aetna by 16.6% in the 3rd quarter. AXA now owns 274,863 shares of the company’s stock valued at $43,706,000 after purchasing an additional 39,125 shares during the period. Wagner Bowman Management Corp boosted its position in Aetna by 44.4% during the 3rd quarter. Wagner Bowman Management Corp now owns 1,954 shares of the company’s stock worth $310,000 after acquiring an additional 601 shares during the last quarter. Shelton Capital Management boosted its position in Aetna by 326.3% during the 3rd quarter. Shelton Capital Management now owns 20,568 shares of the company’s stock worth $3,271,000 after acquiring an additional 15,743 shares during the last quarter. Steward Partners Investment Advisory LLC acquired a new position in Aetna during the 3rd quarter worth approximately $324,000. Finally, Public Employees Retirement System of Ohio boosted its position in Aetna by 6.2% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 245,524 shares of the company’s stock worth $39,041,000 after acquiring an additional 14,324 shares during the last quarter. 88.03% of the stock is owned by institutional investors and hedge funds.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.